| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |